A retrospective real-world study of the current treatment pathways for myelofibrosis in the United Kingdom: the REALISM UK study.

Adam J MeadNauman M ButtWaseem NagiAlastair WhitewaySuriya KirkpatrickCiro RinaldiCatherine RoughleySam AckroydJoanne EwingPratap NeelakantanMamta GargDavid TuckerJohn MurphyHitesh PatelRozinder BainsGavin ChiuJoe HickeyClaire HarrisonTim C P Somervaille

Published in: Therapeutic advances in hematology (2022)

The results of this study suggest that medical records can be missing key information, which is needed to decide which is the best way to treat a patient with myelofibrosis. They also suggest that clinicians in the UK prefer observation to treatment for a large number of patients with myelofibrosis. This could mean that the approach used for many patients with myelofibrosis does not help them to control symptoms that have an impact on their daily lives.

Keyphrases

healthcare
depressive symptoms
sleep quality
replacement therapy
smoking cessation